Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.

Araujo AN, Moraes L, França MI, Hakonarson H, Li J, Pellegrino R, Maciel RM, Cerutti JM.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1104-12. doi: 10.1210/jc.2013-2993. Epub 2014 Mar 6.

PMID:
24601688
2.

Evaluation of RET polymorphisms in a six-generation family with G533C RET mutation: specific RET variants may modulate age at onset and clinical presentation.

Tamanaha R, Camacho CP, Pereira AC, da Silva AM, Maciel RM, Cerutti JM.

Clin Endocrinol (Oxf). 2009 Jul;71(1):56-64. doi: 10.1111/j.1365-2265.2008.03491.x. Epub 2008 Dec 5.

PMID:
19138318
3.

High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.

Sarika HL, Papathoma A, Garofalaki M, Vasileiou V, Vlassopoulou B, Anastasiou E, Alevizaki M.

Clin Endocrinol (Oxf). 2012 Dec;77(6):857-62. doi: 10.1111/j.1365-2265.2012.04462.x.

PMID:
22676047
4.

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.

Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.

Thyroid. 2011 Sep;21(9):975-85. doi: 10.1089/thy.2010.0190. Epub 2011 Aug 11.

PMID:
21834681
5.

The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.

Siqueira DR, Romitti M, da Rocha AP, Ceolin L, Meotti C, Estivalet A, Puñales MK, Maia AL.

Endocr Relat Cancer. 2010 Oct 5;17(4):953-63. doi: 10.1677/ERC-09-0312. Print 2010 Dec.

6.

[The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].

Zhou YL, Zhu SX, Li JJ, Liu JB, Yin M, Xiao BY, Yu CL, Wang LM, Gu LQ, Cui B, Ning G, Li XY, Zhao YJ.

Zhonghua Nei Ke Za Zhi. 2007 Jun;46(6):466-70. Chinese.

PMID:
17663821
7.

Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.

Ceolin L, Siqueira DR, Ferreira CV, Romitti M, Maia SC, Leiria L, Crispim D, Ashton-Prolla P, Maia AL.

Eur J Endocrinol. 2012 May;166(5):847-54. doi: 10.1530/EJE-11-1060. Epub 2012 Feb 17. Erratum in: Eur J Endocrinol. 2012 Jun;166(6):1121. Prolla, Patrícia Ashton [corrected to Ashton-Prolla, Patrícia].

8.

Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.

Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.

Clin Endocrinol (Oxf). 2001 Sep;55(3):399-402.

PMID:
11589684
9.

Clinical case seminar: in vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma.

D'Aloiso L, Carlomagno F, Bisceglia M, Anaganti S, Ferretti E, Verrienti A, Arturi F, Scarpelli D, Russo D, Santoro M, Filetti S.

J Clin Endocrinol Metab. 2006 Mar;91(3):754-9. Epub 2005 Dec 29.

PMID:
16384843
10.

RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.

Qi XP, Ma JM, Du ZF, Ying RB, Fei J, Jin HY, Han JS, Wang JQ, Chen XL, Chen CY, Liu WT, Lu JJ, Zhang JG, Zhang XN.

PLoS One. 2011;6(5):e20353. doi: 10.1371/journal.pone.0020353. Epub 2011 May 31.

11.

C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain.

Abi-Raad R, Virk RK, Dinauer CA, Prasad A, Morotti RA, Breuer CK, Sosa JA, Udelsman R, Rivkees SA, Prasad ML.

Hum Pathol. 2015 Aug;46(8):1121-8. doi: 10.1016/j.humpath.2015.04.011. Epub 2015 May 6.

PMID:
26033033
12.
13.

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. Epub 2007 Sep 25.

PMID:
17895320
14.

Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.

Peppa M, Boutati E, Kamakari S, Pikounis V, Peros G, Panayiotides IG, Economopoulos T, Raptis SA, Hadjidakis D.

Eur J Endocrinol. 2008 Dec;159(6):767-71. doi: 10.1530/EJE-08-0476. Epub 2008 Sep 19. Review.

15.

Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients.

Gursoy A, Erdogan MF, Erdogan G.

J Endocrinol Invest. 2006 Nov;29(10):858-62.

PMID:
17185892
16.

A Korean family of familial medullary thyroid cancer with Cys618Ser RET germline mutation.

Jung J, Uchino S, Lee Y, Park H.

J Korean Med Sci. 2010 Feb;25(2):226-9. doi: 10.3346/jkms.2010.25.2.226. Epub 2010 Jan 21.

17.

[Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].

Zhao JQ, Guo L, Qi XP, Chen ZG, Wang KJ, Lou JL, Yu XH, Cheng J, Jin HY, Li XL, Ying RB, Zhang XN.

Zhonghua Yi Xue Za Zhi. 2013 Feb 5;93(6):440-4. Chinese.

PMID:
23660264
18.

New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.

Frank-Raue K, Döhring J, Scheumann G, Rondot S, Lorenz A, Schulze E, Dralle H, Raue F, Leidig-Bruckner G.

Exp Clin Endocrinol Diabetes. 2010 Aug;118(8):550-3. doi: 10.1055/s-0029-1241851. Epub 2009 Dec 11.

PMID:
20013610
19.

High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.

Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF.

J Clin Endocrinol Metab. 2008 Nov;93(11):4367-72. doi: 10.1210/jc.2008-0912. Epub 2008 Sep 2.

20.

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2008 Mar;93(3):682-7. Epub 2007 Dec 11.

PMID:
18073307
Items per page

Supplemental Content

Write to the Help Desk